Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Oxytocin therapy in hypopituitarism: challenges and opportunities

Bhargava, Raghav, Daughters, Katie L and Rees, D. Aled 2019. Oxytocin therapy in hypopituitarism: challenges and opportunities. Clinical Endocrinology 90 (2) , pp. 257-264. 10.1111/cen.13909
Item availability restricted.

[img] PDF - Accepted Post-Print Version
Restricted to Repository staff only until 2 December 2019 due to copyright restrictions.

Download (3MB)

Abstract

Patients with hypopituitarism display impaired quality of life and excess morbidity and mortality, despite apparently optimal pituitary hormone replacement. Oxytocin is a neuropeptide synthesized in the anterior hypothalamus which plays an important role in controlling social and emotional behaviour, body weight and metabolism. Recent studies have suggested that a deficiency of oxytocin may be evident in patients with hypopituitarism and craniopharyngioma, and that this may be associated with deficits in cognitive empathy. Preliminary data hint at potential benefits of oxytocin therapy in improving these deficits and the accompanying metabolic disturbances that are common in these conditions. However, several challenges remain, including an incomplete understanding of the regulation and mechanisms of action of oxytocin, difficulties in accurately measuring oxytocin levels and in establishing a diagnosis of oxytocin deficiency, and a need to determine both the optimal mode of administration for oxytocin therapy and an acceptable safety profile with long‐term use. This review considers the data linking oxytocin to the neuropsychological and metabolic disturbances evident in patients with craniopharyngioma and hypopituitarism, and describes the challenges that need to be overcome before replacement therapy can be considered as a therapeutic option in clinical practice.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Medicine
Neuroscience and Mental Health Research Institute (NMHRI)
MRC Centre for Neuropsychiatric Genetics and Genomics (CNGG)
Publisher: Wiley
ISSN: 0300-0664
Date of First Compliant Deposit: 28 November 2018
Date of Acceptance: 27 November 2018
Last Modified: 30 Aug 2019 21:04
URI: http://orca.cf.ac.uk/id/eprint/117172

Actions (repository staff only)

Edit Item Edit Item

Downloads

Downloads per month over past year

View more statistics